AtriCure Inc (ATRC)
AtriCure, Inc. is a healthcare equipment company focused on developing, manufacturing, and selling surgical devices used in cardiac ablation, left atrial appendage exclusion, and pain management through peripheral nerve ablation. Its product range includes systems and disposable radio frequency tools for the treatment of cardiac arrhythmias, cryoablation devices, and the EPi-Sense platform for certain forms of atrial fibrillation. The company also markets the AtriClip System, LARIAT System, cryoSPHERE probes, cryoXT probes, and related instruments and accessories used in cardiac and soft-tissue procedures. AtriCure sells its products to medical centers in the United States, the Asia-Pacific region, and other international markets through direct sales personnel and independent distributors. Incorporated in 2000, the company is headquartered in Mason, Ohio.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-ATRC
|
$34.34
|
-0.5% Downside
|
Fair
|
$47
|
36.2% Upside
|
Undervalued
|
Great
|
—
|
—
|
—
|
0.0%
|
July 23, 2026
|
-381.7x
|
3.6x
|
3.2x
|
1.761 B
|
1.682 B
|
4.1%
|
95.9%
|
7.6
|
—
|
-1,167.9%
|
